RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection

Clinical Transplantation

Volumn 21, Issue 3, 2007, Pages 385-390

  Krüger, Bernd ^a   Böger, Carsten A ^a   Obed, Aiman ^b   Farkas, Stefan ^b   Hoffmann, Ute ^a   Banas, Bernhard ^a   Fischereder, Michael ^c   Krämer, Bernhard K ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Kidney transplantation; Rantes; Renal function

Indexed keywords

ALANINE; AZATHIOPRINE; BASILIXIMAB; CREATININE; CYCLOSPORIN A; CYSTEINE; GANCICLOVIR; GLYCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RANTES; STEROID; TACROLIMUS; THREONINE; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GRAFT SURVIVAL; HUMAN; INCIDENCE; INTRON; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME;

ADULT; CHEMOKINES, CC; FEMALE; GENOTYPE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RANTES; RECURRENCE; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34248172494     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00654.x     Document Type: Article

References (27)

1. Joseph JT, Kingsmore DB, Junor BJ et al. The impact of late acute rejection after cadaveric kidney transplantation. Clin Transplant 2001: 15: 221.
2. Nelson PJ, Krensky AM. Chemokines, chemokine receptors, and allograft rejection. Immunity 2001: 14: 377.
3. Rüster M, Sperschneider H, Fünfstück R, Stein G, Gröne HJ. Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. Clin Nephrol 2004: 61: 30.
4. Simeoni E, Winkelmann BR, Hoffmann MM et al. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 2004: 25: 1438.
5. Gröne HJ, Weber C, Weber KS et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment. Faseb J 1999: 13: 1371.
6. Song E, Zou H, Yao Y et al. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int 2002: 61: 676.
7. Gao W, Faia KL, Csizmadia V et al. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation 2001: 72: 1199.
8. Nickel RG, Casolaro V, Wahn U et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000: 164: 1612.
9. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999: 259: 344.
10. Krüger B, Schröppel B, Ashkan R et al. A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol 2002: 13: 2585.
11. Fischereder M, Luckow B, Hocher B et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001: 357: 1758.
12. Böger CA, Fischereder M, Deinzer M et al. RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis 2005: 183: 121.
13. An P, Nelson GW, Wang L et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci USA 2002: 99: 10002.
14. Liu H, Chao D, Nakayama EE et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 1999: 96: 4581.
15. Krüger B, Schnitzbauer AA, Böger CA et al. Pretransplant calcium levels have no predictive value for delayed graft function, long-term graft function, cardiovascular events, or graft and patient survival in renal transplantation. Transplant Proc 2006: 38: 697.
16. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002: 39: S1.
17. Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994: 57: 857.
18. Meier-Kriesche HU, Ojo AO, Hanson JA et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 2000: 70: 1098.
19. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000: 57: 307.
20. Simeoni E, Vassalli G, Seydoux C et al. CCR5, RANTES and CX3CR1 polymorphisms: Possible genetic links with acute heart rejection. Transplantation 2005: 80: 1309.
21. Szalai C, Duba J, Prohaszka Z et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 2001: 158: 233.
22. Hizawa N, Yamaguchi E, Konno S, Tanino Y, Jinushi E, Nishimura M. A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am J Respir Crit Care Med 2002: 166: 686.
23. Bai B, Tanaka K, Tazawa T, Yamamoto N, Sugiura H. Association between RANTES promoter polymorphism -401A and enhanced RANTES production in atopic dermatitis patients. J Dermatol Sci 2005: 39: 189.
24. Gallo RC, Garzino-Demo A, De Vico AL. HIV infection and pathogenesis: what about chemokines? J Clin Immunol 1999: 19: 293.
25. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997: 336: 973.
26. Böger CA, Götz A, Stubanus M et al. C-reactive protein as predictor of death in end-stage diabetic nephropathy: Role of peripheral arterial disease. Kidney Int 2005: 68: 217.
27. Grimes DA, Schulz KF. Bias and causal associations in observational research. Lancet 2002: 359: 248.